Health Law Daily Wrap Up, CONTROLLED SUBSTANCES—FINAL RULES: Designation of P2P Methyl Glycidic Acid as a List I Chemical, (Apr 6, 2026)

By WK Editorial Staff

The Drug Enforcement Administration is finalizing the control of 2-methyl-3-phenyloxirane-2- carboxylic acid (also known as P2P methyl glycidic acid and BMK glycidic acid) and its esters, its optical and geometric isomers, its salts, salts of its optical and geometric isomers and its esters, and any combination thereof, whenever the existence of such is possible, as a list I chemical under the Controlled Substances Act (CSA).

P2P methyl glycidic acid is used in the illicit manufacture of the controlled substances phenylacetone (also known as phenyl-2-propanone or P2P), methamphetamine, and amphetamine, and it is important to the manufacture of these substances. This final rule subjects handlers of P2P methyl glycidic acid to the chemical regulatory provisions of the CSA and its implementing regulations. (Final Rule, 91 Fed. Reg. 16831 (April 3, 2026)).

Dates. This rulemaking will become effective on May 4, 2026. Persons seeking registration must apply on or before May 4, 2026 to continue their business pending final action by DEA on their application.

FederalRegisterIssuances: FinalRules ControlledNews